Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
44.93
+0.28 (0.63%)
At close: Apr 28, 2026, 4:00 PM EDT
45.25
+0.32 (0.71%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Exelixis Employees
Exelixis had 1,077 employees as of December 31, 2025. The number of employees decreased by 70 or -6.10% compared to the previous year.
Employees
1,077
Change (1Y)
-70
Growth (1Y)
-6.10%
Revenue / Employee
$2,154,249
Profits / Employee
$726,620
Market Cap
11.41B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,077 | -70 | -6.10% |
| Dec 31, 2024 | 1,147 | -163 | -12.44% |
| Dec 31, 2023 | 1,310 | 87 | 7.11% |
| Dec 31, 2022 | 1,223 | 269 | 28.20% |
| Dec 31, 2021 | 954 | 181 | 23.42% |
| Dec 31, 2020 | 773 | 156 | 25.28% |
| Dec 31, 2019 | 617 | 133 | 27.48% |
| Dec 31, 2018 | 484 | 112 | 30.11% |
| Dec 31, 2017 | 372 | 85 | 29.62% |
| Dec 31, 2016 | 287 | 172 | 149.57% |
| Dec 31, 2015 | 115 | 17 | 17.35% |
| Dec 31, 2014 | 98 | -129 | -56.83% |
| Dec 31, 2013 | 227 | 53 | 30.46% |
| Dec 31, 2012 | 174 | -26 | -13.00% |
| Dec 31, 2011 | 200 | -183 | -47.78% |
| Dec 31, 2010 | 383 | -293 | -43.34% |
| Dec 31, 2009 | 676 | 0 | - |
| Dec 31, 2008 | 676 | -59 | -8.03% |
| Dec 31, 2007 | 735 | 84 | 12.90% |
| Dec 31, 2006 | 651 | 101 | 18.36% |
| Dec 31, 2005 | 550 | 33 | 6.38% |
| Dec 31, 2004 | 517 | -56 | -9.77% |
| Dec 31, 2003 | 573 | 23 | 4.18% |
| Dec 31, 2002 | 550 | -21 | -3.68% |
| Dec 31, 2001 | 571 | 214 | 59.94% |
| Dec 31, 2000 | 357 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Jazz Pharmaceuticals | 2,890 |
| Ionis Pharmaceuticals | 1,402 |
| Ascendis Pharma | 1,189 |
| Axsome Therapeutics | 925 |
| Madrigal Pharmaceuticals | 915 |
| BridgeBio Pharma | 839 |
| Arrowhead Pharmaceuticals | 711 |
EXEL News
- 7 days ago - Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026 - Business Wire
- 6 weeks ago - Exelixis Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - Exelixis Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Exelixis Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Exelixis Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March - Business Wire
- 2 months ago - Exelixis Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Exelixis Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - Business Wire